Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: WuXi PharmaTech | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: WuXi PharmaTech

Revenues climb 22% in 2011

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi PharmaTech

4Q Revenues: $108.5 million (+23%)

4Q Earnings: $23.5 million (+36%)

FY Revenues: $407.2 million (+22%)

FY Earnings: $81.0 million (+11%)

Comments: In the quarter manufacturing revenues were $15.7 million (+56%) and for year were $75.2 million (+92%). Laboratory services revenue was $92.8 million in the quarter (+18%) and $332.0 million for the year (+13%). China-based lab services accounted for $72.0 million in the quarter, up 21%, and $251.7 million for the year, up 15%. U.S. lab services increased 10% in the quarter to $20.8 million, and increased 6% for the year to $80.3 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters